DK0927037T3 - Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider - Google Patents

Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider

Info

Publication number
DK0927037T3
DK0927037T3 DK97940582T DK97940582T DK0927037T3 DK 0927037 T3 DK0927037 T3 DK 0927037T3 DK 97940582 T DK97940582 T DK 97940582T DK 97940582 T DK97940582 T DK 97940582T DK 0927037 T3 DK0927037 T3 DK 0927037T3
Authority
DK
Denmark
Prior art keywords
chlorofluorocarbons
mometasone furoate
aerosol formulations
aerosol
formulations
Prior art date
Application number
DK97940582T
Other languages
Danish (da)
English (en)
Inventor
Julianne Berry
Joel A Sequeira
Imtiaz A Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0927037T3 publication Critical patent/DK0927037T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK97940582T 1996-08-29 1997-08-26 Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider DK0927037T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29
PCT/US1997/014708 WO1998008519A1 (en) 1996-08-29 1997-08-26 Chlorofluorocarbon-free mometasone furoate aerosol formulations

Publications (1)

Publication Number Publication Date
DK0927037T3 true DK0927037T3 (da) 2001-09-24

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97940582T DK0927037T3 (da) 1996-08-29 1997-08-26 Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider

Country Status (31)

Country Link
EP (1) EP0927037B1 (xx)
JP (1) JP3264496B2 (xx)
KR (1) KR100316358B1 (xx)
CN (1) CN1162157C (xx)
AR (1) AR008309A1 (xx)
AT (1) ATE202936T1 (xx)
AU (1) AU719079B2 (xx)
BR (1) BR9711445A (xx)
CA (1) CA2263905C (xx)
CO (1) CO4900027A1 (xx)
CZ (1) CZ294064B6 (xx)
DE (1) DE69705628T2 (xx)
DK (1) DK0927037T3 (xx)
ES (1) ES2159148T3 (xx)
GR (1) GR3036674T3 (xx)
HK (1) HK1018206A1 (xx)
HU (1) HU227915B1 (xx)
ID (1) ID18137A (xx)
IL (1) IL128714A (xx)
MY (1) MY117377A (xx)
NO (1) NO322528B1 (xx)
NZ (1) NZ334112A (xx)
PE (1) PE100198A1 (xx)
PL (1) PL189036B1 (xx)
PT (1) PT927037E (xx)
SA (1) SA97180339B1 (xx)
SK (1) SK282147B6 (xx)
TR (1) TR199900379T2 (xx)
TW (1) TW475901B (xx)
WO (1) WO1998008519A1 (xx)
ZA (1) ZA977668B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
WO2004018025A1 (en) * 2002-08-23 2004-03-04 Schering Corporation Pharmaceutical compositions
MXPA05002248A (es) * 2002-08-27 2005-06-08 Schering Corp Procedimiento para producir formulaciones de inhalador de dosis medida.
CA2542530A1 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
BRPI0721256A2 (pt) * 2007-02-09 2013-03-12 Schering Corp aerossàis de fÁrmaco farmacÊuticos estÁveis
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
JPH06508149A (ja) * 1991-06-10 1994-09-14 シェリング・コーポレーション クロロフルオロカーボン不含エーロゾル製剤
EP0588897B1 (en) * 1991-06-10 1996-02-28 Schering Corporation Non-chlorofluorocarbon aerosol formulations
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
SA97180339B1 (ar) 2006-01-31
CO4900027A1 (es) 2000-03-27
PL331828A1 (en) 1999-08-02
AU4232997A (en) 1998-03-19
EP0927037B1 (en) 2001-07-11
EP0927037A1 (en) 1999-07-07
SK282147B6 (sk) 2001-11-06
ATE202936T1 (de) 2001-07-15
JP3264496B2 (ja) 2002-03-11
PT927037E (pt) 2001-10-31
HUP9902675A2 (hu) 2000-01-28
TR199900379T2 (xx) 1999-05-21
PE100198A1 (es) 1999-01-11
CZ63299A3 (cs) 1999-07-14
AR008309A1 (es) 1999-12-29
IL128714A (en) 2003-05-29
CA2263905A1 (en) 1998-03-05
CN1233960A (zh) 1999-11-03
DE69705628D1 (de) 2001-08-16
CN1162157C (zh) 2004-08-18
ID18137A (id) 1998-03-05
HU227915B1 (en) 2012-05-29
KR100316358B1 (ko) 2001-12-12
SK25399A3 (en) 1999-12-10
MY117377A (en) 2004-06-30
NO990956D0 (no) 1999-02-26
NZ334112A (en) 2000-07-28
HK1018206A1 (en) 1999-12-17
CA2263905C (en) 2002-05-14
PL189036B1 (pl) 2005-06-30
HUP9902675A3 (en) 2000-02-28
ZA977668B (en) 1998-02-26
KR20000035879A (ko) 2000-06-26
JP2000503673A (ja) 2000-03-28
GR3036674T3 (en) 2001-12-31
DE69705628T2 (de) 2002-05-08
NO322528B1 (no) 2006-10-16
CZ294064B6 (cs) 2004-09-15
IL128714A0 (en) 2000-01-31
BR9711445A (pt) 1999-08-24
TW475901B (en) 2002-02-11
AU719079B2 (en) 2000-05-04
NO990956L (no) 1999-04-28
ES2159148T3 (es) 2001-09-16
WO1998008519A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
ATE236617T1 (de) Aerosol-arzneiformulierungen
DK0934057T3 (da) Medicinske aerosolformuleringer med formoterol
DK1073417T3 (da) Farmaceutisk aerosolformulering
EE9900055A (et) Farmatseutilised aerosoolkompositsioonid
DK0625046T3 (da) Farmaceutiske aerosolformuleringer indeholdende beclomethasondipropionat
ATE245969T1 (de) Stabile glasartige pulverformulierungen
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
NO20004540L (no) Sammensetninger av peptider, formuleringer og anvendelse derav
NO920987D0 (no) Farmasoeytiske aerosolformuleringer
ID20611A (id) Formulasi pelindung terhadap uv
DK0927037T3 (da) Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider
ID18832A (id) Komposisi insektisida
ID16781A (id) Formulasi-formulasi farmasi
ID23873A (id) Produk-produk semprot aerosol anti-perspiran mengandung alkohol
ID23693A (id) Formulasi bambuterol, pembuatan dan penggunaanya
NO991430L (no) Insektfordrivende formuleringer
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
SE9502452D0 (sv) Aerosol formulations
HUP0001536A3 (en) Sulfonamide and carboxamide derivatives and pharmaceutical compositions containing the same as the active ingredient
NO961025D0 (no) Skumformulering av oljer
ITMI920660A0 (it) Nuovo derivato di l-verbenone e composizioni farmaceutiche che lo contengono
SE9600141D0 (sv) Pharmaceutical formulation
ECSP951374A (es) Composiciones para pulverizaciones nasales